In contrast to PARP1 depletion, poisoning the HR machinery by PARP inhibition sensitized both parental and irinotecan resistant CRC cells to irinotecan, which is consistent with the published literature in other cancer types (63). This evidence concerns the gene PARP1 and cancer.